⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL83813 | 0.85 | — | — | |
| SCHEMBL9438417 | 0.82 | ALDH1A1 (0.30) | — | |
| SCHEMBL1717671 | 0.74 | TSHR (0.39) | — | |
| SCHEMBL22999304 | 0.74 | — | — | |
| SCHEMBL2007850 | 0.73 | — | — | |
| SCHEMBL2007851 | 0.73 | — | — | |
| SCHEMBL10811420 | 0.73 | — | — | |
| SCHEMBL7362361 | 0.71 | ALDH1A1 (0.37) | — | |
| SCHEMBL28706081 | 0.71 | — | — | |
| SCHEMBL4619187 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202322-B2 | Resorcinol derivatives | SUTTER BAY HOSPITALS (US) | 2019-02-12 | — | — | US | claimed |
| US-20180170846-A1 | RESORCINOL DERIVATIVES | SUTTER WEST BAY HOSPITALS | 2018-06-21 | — | — | US | claimed |
| US-20130209483-A1 | CANNABIDINOID DERIVATIVES | SUTTER WEST BAY HOSPITALS (US) | 2013-08-15 | — | — | US | claimed |
| US-20130087745-A1 | SOLUBLE PRECURSORS AND SOLUTION-BASED PROCESSES FOR PHOTOVOLTAICS | PRECURSOR ENERGETICS, INC. (US) | 2013-04-11 | — | — | US | claimed |
| CN-118159373-A | Sintered material, metal sintered body, method for producing sintered material, method for producing joined body, and joined body | 凸版控股株式会社 | 2024-06-07 | — | — | CN | disclosed |
| US-20240174947-A1 | SURFACTANT COMPOSITIONS | LANKEM LTD. (GB) | 2024-05-30 | — | — | US | disclosed |
| EP-4373529-A1 | FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2024-05-29 | — | — | EP | disclosed |
| EP-4372019-A1 | NOVEL (METH)ACRYLAMIDE POLYMER, RESIN COMPOSITION CONTAINING SAME, AND MOLDED BODY THEREOF | Nippon Soda Co., Ltd. (JP) | 2024-05-22 | — | — | EP | disclosed |
| US-20240115745-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2024-04-11 | — | — | US | disclosed |
| CN-113164361-B | Personal care compositions | 高露洁-棕榄公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117769443-A | Fibroblast activation protein inhibitor and use thereof | 3B制药有限公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2024052431-A1 | PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2024-03-14 | — | — | WO | disclosed |
| US-5886108-A | Process for hydrogenating conjugated diene polymer | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-03-23 | — | — | US | disclosed |
| EP-0889057-A1 | Process for hydrogenating conjugated diene polymer | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0889097-A1 | PHTHALOCYANINE COMPOUNDS, PROCESS FOR PREPARING THE SAME, AND OPTICAL RECORDING MEDIUM MADE USING THE SAME | NIPPON SHOKUBAI CO., LTD. (JP) | 1999-01-07 | — | — | EP | disclosed |
| EP-0818512-A1 | Quinoline derivative and use of same | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1998-01-14 | — | — | EP | disclosed |
| US-5455262-A | Treating arthritis, tumor metastasis, periodontal disease, corneal ulceration, bone resorption diseases, glomerular diseases | FLORIDA STATE UNIVERSITY (US) | 1995-10-03 | — | — | US | disclosed |
| US-5298038-A | Cleaning coke from injection nozzle | KAO CORPORATION (JP) | 1994-03-29 | — | — | US | disclosed |
| EP-0353713-B1 | Use of an additive for fuel | KAO CORP (JP) | 1994-03-16 | — | — | EP | disclosed |
| EP-0353713-A1 | Use of an additive for fuel | Kao Corporation (JP) | 1990-02-07 | — | — | EP | disclosed |